Outbreak of exogenous Cushing's syndrome due to unlicensed medications

Clinical Endocrinology

Volumn 69, Issue 6, 2008, Pages 921-925

  Azizi, Fereidoun ^a,b   Jahed, Adel ^c   Hedayati, Mehdi ^b   Lankarani, Mahnaz ^d   Bejestani, Hadi Shahrad ^e   Esfahanian, Fatemeh ^f   Beyraghi, Nargues ^b   Noroozi, Alireza ^g   Kobarfard, Farzad ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCODEINE; BUPRENORPHINE; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DIAMORPHINE; PHENIRAMINE; PREDNISOLONE; TAMGESIC; UNCLASSIFIED DRUG;

ADRENAL CORTEX INSUFFICIENCY; ADULT; ARTICLE; CLINICAL ARTICLE; CUSHING SYNDROME; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG TRAFFIC; EPIDEMIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; IATROGENIC DISEASE; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; CUSHING SYNDROME; DEXAMETHASONE; DRUG CONTAMINATION; HUMANS; HYDROCORTISONE; IATROGENIC DISEASE; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OPIUM; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 55949125885     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03290.x     Document Type: Article

References (21)

1. Axelrod, L. (1989) Side effects of glucocorticoid therapy. In : R.P. Schleimer, H.N. Claman, A.L. Oronsky eds. Anti-Inflammatory Steroid Action Basic and Clinical Aspects. Academic Press, San Diego 377 408.
2. Cizza, G., Nieman, L.K., Doppman, J.L., Passaro, M.D., Czerwiec, F.S., Chrousos, G.P. Cutler, G.B. Jr. (1996) Factitious Cushing syndrome. Journal of Clinical Endocrinology and Metabolism, 81, 3573 3577.
3. Gethin Morgan, G., Boulnois, J. Burns-Cox, C. (1973) Addiction to prednisone. British Medical Journal, 2, 93 94.
4. Witt, M.E. Ginsberg-Fellner, F. (1981) Prednisone-induced Munchausen syndrome. American Journal of Disease Child, 135, 852 853.
5. Cook, D.M. Meikle, A.W. (1985) Factitious Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 61, 385 387.
6. O'Hare, J.P.O., Vale, J.A., Wood, S. Corrall, R.J.M. (1986) Factitious Cushing's syndrome. Acta Endocrinologica (Copenhagen), 111, 165 167.
7. Workman, R.J., Nicholson, W.E. McCammon, D.K. (1995) Factitious hypercortisoluria. Journal of Clinical Endocrinology and Metabolism, 80, 3050 3051.
8. Sastre, J., Diez, J.J., Lopez, G., Iglesias, P., Matinez, I. Gomez, P.A. (1994) Self-induced Cushing's syndrome due to dexamethasone abuse in nasal spray: clinical and biochemical study. Anales de Medicina Interna, 11, 181 184.
9. Teelucksingh, S., Bahall, M., Coomansingh, D., Suite, M. Bartholomew, C. (1993) Cushing's syndrome from topical glucocorticoids. West Indian Medical Journal, 42, 77 78.
10. Imam, A.P. Halpern, G.M. (1994) Uses, adverse effects of abuse of glucocorticoids. Allergologia et Immunopathologia (Madr), 22, 250 260.
11. Kumar, V., Mostafa, S., Kayo, M.W., Goldberg, E.P. Derendorf, H. (2006) HPLC determination of dexamethasone in human plasma and its application to an in vitro release study from endovascular stents. Pharmazie, 61, 908 911.
12. Asher, R. (1951) Munchausen's Syndrome. Lancet, 339 341.
13. Grunberger, G., Weiner, J.L., Silverman, R., Taylor, S. Gorden, P. (1988) Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Annals of Internal Medicine, 108, 252 257.
14. Mariotti, S., Martino, E., Cupini, C., Lari, R., Giani, C., Baschieri, L. Pinchera, A. (1982) Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. New England Journal of Medicine, 307, 410 412.
15. Keiser, H.R. (1991) Surreptitious self-administration of epinephrine resulting in 'pheochromocytoma'. Journal of the American Medical Association, 266, 1553 1555.
16. Quddusi, S., Browne, P., Toivola, B. Hirsch, I.B. (1998) Cushing syndrome due to surreptitious glucocorticoid administration. Archives of Internal Medicine, 58, 294 296.
17. Lin, C., Wu, T., Machacek, D.A. Jiang, N. (2006) Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 151 155.
18. Taylor, R.L., Grebe, S.K. Singh, R.J. (2004) Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clinical Chemistry, 50, 2345 2352.
19. Boscaro, M., Barzon, L. Sonino, N. (2000) The diagnosis of Cushing's syndrome, atypical presentations and laboratory shortcomings. Archives of Internal Medicine, 160, 3045 3053.
20. Lamberts, S.W.J., Bruining, H.A. de Jong, F.H. (1997) Corticosteroid therapy in severe illness. New England Journal of Medicine, 337, 1285 1292.
21. Cooper, M. Stewart, P. (2003) Corticosteroid insufficiency in acutely ill patients. New England Journal of Medicine, 348, 727 734.